RMD · News · 20260809N
Net Income and EPS Performance
RESMED INC · 2026-08-09 · Importance 23 · Surprise 22 · In source text
Fourth-quarter fiscal 2026 non-GAAP earnings per share increased 16% year over year to $2.95. Full-year fiscal 2026 EPS was $10.43, according to the annual-results report. The 16% quarterly EPS increase exceeds the specified 10% materiality threshold even though the digest does not provide quarterly net income or operating-income figures.
Key facts
- Analysts project ResMed 2027 EPS of US$11.52. source
- Non-GAAP earnings per share rose 16% to $2.95 in fourth-quarter fiscal 2026. source
- ResMed reported annual EPS of US$10.43. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | unclear | contingent | — | Analysts project ResMed 2027 EPS of US$11.52. |